Journals / Mersin Üniversitesi Sağlık Bilimleri Dergisi / 2008 / Cilt: 1 - Sayı: 3

Nikotin ve Antagonisti Mecamylaminin Kurbağa (Rana ridibunda) İskelet Kası Üzerine Etkileri

Pages
14–20
Publication Date
2008-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On the other hand mecamylamine inhibited the contraction force of skeletal muscle alone.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractThe Effects of Nicotine and Its Antagonist Mecamylamine on Skeletal Muscle of Frog (Rana ridibunda) Objective: In this study, we investigated the effects of nicotine which is the active ingredient of smoke and a therapeutic agent mecamylamine which is the nicotinic antagonist on contraction force of isolated frog gastrocnemius muscle depending on application time.
📊
Key Findings & Data:Method: The study was composed of three experimental groups; 10-4M nicotine, 10-4M mecamylamine and 10-4M nicotine + 10-4M mecamylamin combination.
💡
Conclusion & Impact:On the other hand mecamylamine inhibited the contraction force of skeletal muscle alone.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:nikotin · mecamylamin · gastrokinemius kası

Abstract

AbstractThe Effects of Nicotine and Its Antagonist Mecamylamine on Skeletal Muscle of Frog (Rana ridibunda) Objective: In this study, we investigated the effects of nicotine which is the active ingredient of smoke and a therapeutic agent mecamylamine which is the nicotinic antagonist on contraction force of isolated frog gastrocnemius muscle depending on application time. Method: The study was composed of three experimental groups; 10-4M nicotine, 10-4M mecamylamine and 10-4M nicotine + 10-4M mecamylamin combination. Ten frog gastrocnemius muscles were investigated in each group (n=30). Measurements were taken at 0th, 30th, 60th, 90th, 120th minutes. Measurements at 0th minute were the control of the preparation of muscles. Contraction recordings were obtained by BIOPAC MP 100 Acqusition System and maximum contraction force was used. Result: Nicotine and its antagonist mecamylamine decreased the contraction force 48% and 81% at 120th minute respectively when compared with control (p<0.05). Nicotine and mecamylamine combination group displayed no changes in contraction force at each threatment time segment. Conclusion: As a result nicotine showed an inhibition effect on contraction force of skeletal muscle in threatment time. This effect of nicotine was reversed by mecamylamine. On the other hand mecamylamine inhibited the contraction force of skeletal muscle alone.

Özet

Türkçe Özet:Amaç: Bu çalışmada, sigaranın etken maddesi olarak kabul edilen nikotin ile birçok alanda tedavi edici ajan olarak da kullanılan nikotin antagonisti mecamylaminin, izole kurbağa gastrokinemius kası kasılma kuvveti üzerine etkisinin, uygulama süresine bağlı olarak değişiminin araştırılması amaçlanmıştır. Yöntem: Çalışmada 10-4M nikotin, 10-4M mecamylamin ve 10-4M nikotin + 10-4M mecamylamin kombinasyon grubu olmak üzere üç ayrı deney grubu oluşturulmuştur. Her bir deney grubu için on gastrokinemius kası çalışılmıştır (n=30). Süreye bağlı etkileri inceleyebilmek için ölçümler 0., 30., 60., 90. ve 120. dakikalarda alınmıştır. Sıfırıncı dakikadaki ölçüm kas preparatın kendi kontrolüne karşılık gelmektedir. Kasılma eğrilerini kaydetmek için BIOPAC MP 100 Acqusition sistemi kullanılmıştır. Elde edilen kayıtlardan maksimum kasılma kuvveti ölçülmüştür. Bulgular: Nikotin ve mecamylaminin ayrı ayrı uygulandığı deney gruplarında her iki madde kasılma kuvvetini kontrole göre uygulamanın 120. dakikasında sırasıyla %48 ve %81 oranında azaltmıştır (p<0.05). Nikotin ve mecamylamin kombinasyonunun uygulandığı deney grubunda ise aynı dozlar kasılma kuvvetinde kontrole göre herhangi bir değişikliğe yol açmamıştır (p>0.05). Sonuç: Bu çalışma sonucunda nikotin zamana bağlı olarak iskelet kası kasılma kuvveti üzerine inhibe edici bir etki göstermiştir. Nikotinin bu etkisi mecamylamin tarafından ortadan kaldırılmıştır. Ancak bir nikotin antagonisti olan mecamylamin tek başına iskelet kası kasılma kuvvetini inhibe edici bir etki sergilemektedir.

🔖

Cite This Article

KUMARGAL, D., ÇÖMELEKOĞLU, Ü., AŞKIN, A. (2008). Nikotin ve Antagonisti Mecamylaminin Kurbağa (Rana ridibunda) İskelet Kası Üzerine Etkileri. Mersin Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 1 - Sayı: 3, 14–20. https://ajindex.com/articles/44173

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Ke L, Eisenhour CM, Bencherif M, Lukas RJ. Effects of chronic nicotine threatment on expressionof diverse nicotinic acethylcholine receptor subtypes I dose— and time— dependent effects of nicotine threatment. J Pharmacol Exp Ther 1998;286:825-40
  2. Karlıkaya C, Öztuna F, Solak ZA, Özkan M, Örsel O. Tütün Kontrolü. Türk Toraks Dergisi 2006;7(1):51-64.
  3. Peto R, Lopez A, Boreham J, Thun M, Heath C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992;339:1268—78. Casida JE, Quistad GB. Golden age of insecticide research: past, present and future. Annu Rev Entomol 1998;43:1-16.
  4. Copping LG, Menn JJ. Biopesticides: A review of their action, applications and efficacy. Pest Manag Sci 2000;56(8):651—676. Gepner JI, Hall LM, Sattelle DB. Insect acethylecholine receptors as a site of insecticide action. Nature l978;276(5684)1188-90.
  5. Gray JA, Mitchell SN, Joseph MH, Grogoryan GA, Dawe S, Hodges H. Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Dev Res 1994;31:3—17 Henningfield JE, Schuh LM, Heishman SJ. Pharmacological determinants of cigarette smoking. Clarke PBS, Quik M, Adlkofer F, Thurau K. Effects of Nicotine on Biyological Systems II 2'”1 Ed., Basel: Birkha user Verlag, 1995:127—35. Warburton DM. The functional conception of nicotine use. Clarke PBS, Quik M, Adlkofer F, Thurau K. Effects of Nicotine on Biyological Systems II 2nd Ed., Basel: Birkha user Verlag, 1995:257-64. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Narahashi T. Ion Channels, 4nd Ed., New York: Plenum Pres, 1996:377—450. ll. Lukas RJ, Ke L, Bencherif M, Eisenhour CM. Regulation by nicotine of its own receptors. Drug Dev Res 1996;38:136-48. Lukas RJ. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromacytoma or the TE67l/RD human clonal line. J Neurochem 1991;56:134—45. Young JM, Shytle RD, Sanberg PR, George TP. Mecamylamine: new therapeutic uses and toxicity/risk Stolerman IP, Goldfarb T, Fink R, Jarvik ME. Inşuencing cigarette smoking with nicotine antagonists. Pickworth WB, Fant RV, Butschky MF, Henningfield JE. Effects of mecamylamine on spontaneous EEG and Eissenberg T, Griffiths RR, Stitzer ML. Mecamylamine does not precipitate with-drawal in sigarette smokers. Tennant FS, Tarver AL, Withdrawal from nicotine dependence using mecamylamine: Comparission of three— Rose JE, Sampson A, Le